https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-08-01 / Int J Hyperthermia 2007 Aug;23(5):417-292007-08-01 00:00:002007-08-01 00:00:00Benefits of superficial hyperthermia treatment planning: five case studies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-07-15 / Cancer Res. 2007 Jul;67(14):6531-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-07-15 / Cancer Res. 2007 Jul;67(14):6531-42007-07-15 00:00:002007-07-15 00:00:00Development of vaccines for high-risk ductal carcinoma in situ of the breast
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-07-01 / Anticancer Res. 2007 Jul-Aug;27(4B):2121-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-07-01 / Anticancer Res. 2007 Jul-Aug;27(4B):2121-92007-07-01 00:00:002007-07-01 00:00:00Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-06-01 / J. Exp. Clin. Cancer Res. 2007 Jun;26(2):201-72007-06-01 00:00:002007-06-01 00:00:00Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):345-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):345-82007-03-01 00:00:002007-03-01 00:00:00Counterpoint: Hyperthermia with radiation therapy for chest wall recurrences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):339-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-01 / J Natl Compr Canc Netw 2007 Mar;5(3):339-442007-03-01 00:00:002007-03-01 00:00:00Point: Hyperthermia with radiation for chest wall recurrences
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-09 / Cancer Res 2007 Feb;67(4):1842-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-09 / Cancer Res 2007 Feb;67(4):1842-522007-02-09 00:00:002023-03-07 13:12:37Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-07 / Cancer Immunol Immunother 2007 Sep;56(9):1485-99
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-07 / Cancer Immunol Immunother 2007 Sep;56(9):1485-992007-02-07 00:00:002023-03-07 13:13:36Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-03 / Vaccine 2007 Mar;25(14):2610-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-03 / Vaccine 2007 Mar;25(14):2610-92007-01-03 00:00:002007-01-03 00:00:00Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Jan;23(1):60-22007-01-01 00:00:002007-01-01 00:00:00[Induction of specific CTL by DC from axillary lymph node of patients with breast cancer]